AUPH | Aurinia PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$16.56
+$0.42 (+2.60%)

Aurinia Pharmaceuticals (AUPH) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $16.56 vs 50 $16.48 / 200 $15.66
Projection
No cross projected
Test
No active test
Last cross
Golden cross 26 Sep 2024 ยท projected 29 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $16.65 vs 50 $15.58 / 200 $10.25
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 6 Oct 2025 ยท projected 28 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $16.56 vs 50 $16.55 / 200 $16.22
Projection
No cross projected
Test
No active test
Last cross
Golden cross 8 Sep 2026 ยท projected 16 bars out

Cross history

28
crosses on record since 2017
14 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
8 Sep 2026Golden4-hour16 bars outโ€”
4 Aug 2026Death4-hour28 bars out3 bar cross test
20 Apr 2026Golden4-hour28 bars outNot tested
3 Mar 2026Death4-hour23 bars out4 bar cross test
week of 6 Oct 2025Golden moderateweekly28 bars outNot tested

About AUPH

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$13M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.